...
首页> 外文期刊>Molecular and cellular neurosciences >Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease
【24h】

Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease

机译:脂蛋白蛋白磷酸酶2A的下调e:对阿尔茨海默病的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract The apolipoprotein E ε4 allele is the single most important genetic risk factor associated with Alzheimer's disease (AD). Tau phosphorylation and hyperphosphorylation is an underlying feature of AD and is regulated by specific kinases and phosphatases. Among phosphatases, protein phosphatase 2A (PP2A) is the principal tau dephosphorylating enzyme in the brain. Several abnormalities of PP2A have been reported in AD, including among others decreased protein levels of PP2A, decreased mRNA and protein levels of the catalytic subunit PP2AC and variable regulatory B subunits and reduced methylation of the catalytic subunit, all of which results in disruption of the PP2A phosphatase activity. In earlier studies we described a novel mechanism for ApoE as a transcription factor that binds regions of double-stranded DNA with high affinity, including the promoter regions of ~3000 different genes. The list of genes also included PPP2R5E (B56ε), a regulatory B′ subunit of protein phosphatase 2A. Using a combination of A172 human glioblastoma cells, ApoE3/4 and ApoE?/? NSC and human postmortem tissue, we now demonstrate that ApoE not only binds to the PPP2R5E promoter but also triggers a significant reduction in PP2A activity by two mechanisms: 1) ApoE transcriptionally represses PPP2R5E and reduces protein expression, and 2) ApoE triggers demethylation of the catalytic subunit (PP2AC) of PP2A, resulting in the disruption of the PPP2R5E-PP2AC complex. Our results indicated a significant down-regulation of PPP2R5E gene expression and reduction in PP2A activity by ApoE4 compared with ApoE3. This may also explain an elevated Tau phosphorylation in AD human brains that featured at least one ApoE4 allele. Thus, our present work links ApoE and PPP2R5E expression to a reduction in the PP2A catalytic activity that has implications for Alzheimer's disease. Highlights ? ApoE transcriptionally represses PPP2R5E, a regulatory B′ subunit of protein phosphatase 2A. ? ApoE triggers demethylation of the catalytic subunit (PP2AC) of PP2A. ? Together, this results in the disruption of the PPP2R5E-PP2AC complex and in PP2A activity. ? Our work linking ApoE to a reduction in the PP2A activity has implications for Alzheimer's disease.
机译:<![cdata [ 抽象 载脂蛋白Eε4等位基因是与阿尔茨海默病(广告)相关的单一重要遗传危险因素。 Tau磷酸化和高磷酸化是AD的底层特征,并由特定激酶和磷酸酶调节。在磷酸酶中,蛋白质磷酸酶2a(pp2a)是大脑中的主要Taphysphorylated酶。已在AD中报告了几种PP2a异常,包括其他PP2A的蛋白质水平降低,催化亚单位pp2a的mRNA和蛋白质水平降低 c 和可变调节b亚单位和催化亚基的甲基化降低,所有这些都导致PP2A磷酸酶活性的破坏。在早期的研究中,我们描述了一种新的APOE机制作为与高亲和力结合双链DNA区域的转录因子,包括〜 3000种不同基因的启动子区域。基因列表还包括PPP2R5E(B56ε),蛋白质磷酸酶2a的调节B'亚基。使用A172人胶质母细胞瘤细胞的组合,apoe 3/4 和apoe ?/? NSC和人类后期组织,我们现在证明了atPoE不仅与PPP2R5E启动子结合,而且还通过两种机制触发PP2A活性的显着降低:1)ApoE转录抑制PPP2R5E并减少蛋白质表达,2)ApoE触发蛋白质表达,并触发除去物PP2A的催化亚单元(PP2A C ),导致PPP2R5E-PP2A C 复杂。我们的结果表明,与ApoE3相比,通过ApoE4对PPP2R5E基因表达的显着下调PPP2R5E基因表达和通过ApoE4降低PP2A活性。这也可以解释在具有至少一个APOE4等位基因的AD人性大脑中的TAU磷酸化升高。因此,我们的本作工作链接ApoE和PPP2R5E表达对具有对阿尔茨海默病有影响的PP2A催化活性的表达。 突出显示 ?< / ce:标签> apoe转录抑制ppp2r5e,蛋白质磷酸酶2a的调节b'亚基。 < CE:列表 - 项目ID =“LI0010”> ApoE触发催化亚基的去甲基化(PP2A c )pp2a。 在一起,这导致PPP2R5E-PP2A C 复合物和PP2A活动中的中断。 < / ce:list-item> 我们的工作链接apoe降低PP2A活动对阿尔茨海默病有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号